A detailed history of Bank Of America Corp transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 2,748,850 shares of DNA stock, worth $22.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,748,850
Previous 3,117,232 11.82%
Holding current value
$22.4 Million
Previous $3.62 Million 74.91%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.28 - $1.16 $103,146 - $427,323
-368,382 Reduced 11.82%
2,748,850 $907,000
Q1 2024

May 15, 2024

BUY
$1.06 - $1.67 $656,269 - $1.03 Million
619,122 Added 24.78%
3,117,232 $3.62 Million
Q4 2023

Feb 14, 2024

SELL
$1.26 - $1.79 $170,001 - $241,510
-134,922 Reduced 5.12%
2,498,110 $4.22 Million
Q2 2023

Aug 14, 2023

BUY
$1.14 - $1.95 $132,501 - $226,646
116,229 Added 4.62%
2,633,032 $4.9 Million
Q1 2023

May 12, 2023

BUY
$1.2 - $2.19 $358,026 - $653,397
298,355 Added 13.45%
2,516,803 $3.35 Million
Q4 2022

Feb 10, 2023

SELL
$1.63 - $3.52 $961,519 - $2.08 Million
-589,889 Reduced 21.0%
2,218,448 $3.75 Million
Q3 2022

Nov 14, 2022

BUY
$0.73 - $3.74 $442,116 - $2.27 Million
605,639 Added 27.5%
2,808,337 $8.76 Million
Q2 2022

Aug 12, 2022

SELL
$2.2 - $4.2 $1 Million - $1.92 Million
-456,223 Reduced 17.16%
2,202,698 $5.24 Million
Q1 2022

May 16, 2022

BUY
$2.83 - $8.69 $4.17 Million - $12.8 Million
1,475,116 Added 124.61%
2,658,921 $10.7 Million
Q4 2021

Feb 08, 2022

BUY
$8.31 - $14.92 $9.11 Million - $16.4 Million
1,096,575 Added 1257.11%
1,183,805 $9.84 Million
Q3 2021

Nov 15, 2021

BUY
$9.15 - $13.28 $798,154 - $1.16 Million
87,230 New
87,230 $1.01 Million

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.5B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.